Search

Your search keyword '"Doz, F."' showing total 27 results
Start Over Author "Doz, F." Journal archives de pediatrie
27 results on '"Doz, F."'

8. Neurofibromatose 1 : recommandations de prise en charge

Author

Pinson, S, Créange, A, Barbarot, S, Stalder, J.F, Chaix, Y, Rodriguez, D, Sanson, M, Bernheim, A, d’Incan, M, Doz, F, Stoll, C, Combemale, P, Kalifa, C, Zeller, J, Teillac-Hamel, D, Lyonnet, S, Zerah, M, Lacour, J.P, Guillot, B, and Wolkenstein, P

Published
2002
Full Text
View/download PDF

9. CL100 - Place de la chimiothérapie selon le protocole BBSFOP dans les gliomes des voies optiques (GVO) avec cachexie diencéphalique (CD) de l’enfant : étude rétrospective de la SFCE (Société Française des Cancers de l’Enfant)

Author

Bobillier-Chaumont, S., primary, Laithier, V., additional, Raquin, M.A., additional, Jochault, L., additional, Rialland, X., additional, Sariban, E., additional, Fouyssac, F., additional, Bertozzi, A.I., additional, Doz, F., additional, Frappaz, D., additional, and Grill, J., additional

Published
2010
Full Text
View/download PDF

10. CL088 - Prédisposition génétique au neuroblastome

Author

De Pontual, L., primary, Brugieres, L., additional, Valteau-Couanet, D., additional, Frebourg, T., additional, Michon, J., additional, Doz, F., additional, Delattre, O., additional, Janoueix-Lerosey, I., additional, Lyonnet, S., additional, and Amiel, J., additional

Published
2010
Full Text
View/download PDF

13. Le médulloblastome de l’enfant

Author

Yazigi-Rivard, L., primary, Masserot, C., additional, Lachenaud, J., additional, Diebold-Pressac, I., additional, Aprahamian, A., additional, Avran, D., additional, and Doz, F., additional

Published
2008
Full Text
View/download PDF

16. Hypercalcémie chez l'enfant cancéreux

Author

Kerdudo, C., primary, Aerts, I., additional, Fattet, S., additional, Chevret, L., additional, Pacquement, H., additional, Doz, F., additional, Michon, J., additional, Garabedian, M., additional, and Orbach, D., additional

Published
2005
Full Text
View/download PDF

21. Le Traitement Actuel Du Retinoblastome

Author

Doz, F., primary, Levy, C., additional, Lumbroso, L., additional, Schlienger, P., additional, Validire, P., additional, Asselain, B., additional, Desjardins, L., additional, and Zucker, J.M., additional

Published
1999
Full Text
View/download PDF

26. Central neurological manifestations during chemotherapy in children

Author

Orbach, D., Brisse, H., and Doz, F.

Subjects
*NEUROTOXICOLOGY, *DRUG therapy, *ANTINEOPLASTIC agents, *BLOOD-brain barrier, *ALKYLATING agents
Abstract

The central neurotoxicity of cytotoxic drugs depends on their ability to cross the blood-brain barrier (BBB). The drugs with the highest neurotoxicity are therefore those that cross the BBB most easily: alkylating agents (metabolites of cyclophosphamide and ifosfamide, thiotepa and high-dose melphalan), busulfan, platinum derivatives, aracytine and methotrexate. Apart from aracytine-induced cerebellar toxicity, the clinical signs suggestive of chemotherapy neurotoxicity are relatively nonspecific: altered level of consciousness, seizures, behavioural disorders and motor deficits. Nevertheless, a good knowledge of the various neurological syndromes likely to occur can allow them to be attributed to a drug-induced cause. However, as patients may be receiving several potentially neurotoxic treatments (chemotherapy, concomitant drugs, neurosurgery, radiotherapy), it is difficult to formally confirm the responsibility of the drug, which should only be considered after confirming the absence of radiological and metabolic abnormalities. A specific antagonist treatment can be administered in rare cases (ifosfamide-induced encephalopathy). [Copyright &y& Elsevier]

Published
2003
Full Text
View/download PDF

27. Guidelines for the management of neurofibromatosis 1.

Author

Pinson, S., Créange, A., Barbarot, S., Stalder, J.F., Chaix, Y., Rodriguez, D., Sanson, M., Bernheim, A., d’Incan, M., Doz, F., Stoll, C., Combemale, P., Kalifa, C., Zeller, J., Teillac-Hamel, D., Lyonnet, S., Zerah, M., Lacour, J.P., Guillot, B., and Wolkenstein, P.

Subjects
*NEUROFIBROMATOSIS, *MAGNETIC resonance imaging, *GLIOMAS
Abstract

Twenty experts, members of a French medical network devoted to neurofibromatosis 1 have elaborated recommendations for the management of the disease. Bibliography was obtained through a Medline of articles from 1966 to 1999 for the terms neurofibromatosis, NF1, neurofibroma and from textbooks. A consensual document was written taking into account extracted data. An annual careful clinical examination is recommended except in cases with complications. Screening investigations are not recommended due to the rarity of complications, generally symptomatic and easily detected during the clinical follow-up. The only controversial exception might be magnetic resonance imaging for early detection of optic pathway gliomas in young children. A co-ordinated follow-up in specialised multidisciplinary centres, providing patients with a rational management, is recommended. [ABSTRACT FROM AUTHOR]

Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results